Triastek
Nanjing
About Triastek
Triastek develops 3D printed medicines and the production facilities to manufacture them and has already filed patent applications for its technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $102.4M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2023)
- Website: triastek.com
- Phone: 86-25-52713121
Industries & Categories
3D Printing, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/triastek-110180 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.